XML 21 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
NOTE 4 - ACQUISITION OF THE CONSORTIUM
9 Months Ended
Sep. 30, 2018
Notes  
NOTE 4 - ACQUISITION OF THE CONSORTIUM

NOTE 4 – ACQUISITION OF THE CONSORTIUM

 

On July 14, 2018, NewBridge closed on Share Exchange and Purchase Agreements (“Closing”) with the various members and shareholders of 11th Street, Mad Creek, Timothy, Genus (formerly GLML), Roots Nursery, Inc. (“Roots”), and 5Leaf (together the “Consortium”), whereby NewBridge purchased the shares or membership interests (as the case may be) of the entities making up the Consortium for a total of 31,000,000 shares of the Company’s common stock, par value $0.0001 per share. The Consortium consists of a farm, nursery, management and real estate companies with plans to operate in the cannabis industry.  

 

The 31,000,000 shares issued to the Consortium represented 76% of the 40,904,589 shares of the Company’s common stock issued and outstanding immediately following the July Acquisitions. In addition, three of the four board members were replaced by the sellers at the Close. Due to the relative size of the Consortium compared to the Company prior to the Closing and the change in control of the Company, the July Acquisitions were considered a reverse acquisition and the Consortium is the acquirer for accounting purposes.

On September 12, 2018, NewBridge provided Roots notice of termination of the Roots Agreement pursuant to Section 10.01 of the Roots Nursery, Inc. Share Exchange and Purchase Agreement (the “Termination Agreement”), effective immediately.  Pursuant to the Termination Agreement, the Company cancelled a total of 9,850,000 shares of Common Stock issued in connection with the July 14 Closing.  On the same day, the Company issued a total of 9,850,000 shares to acquire East 10th Street LLC, a California limited liability real estate company, for 2,925,000 shares of the Company’s common stock and the rights to certain trademarks, logos, business operating procedures, marketing material and future plans for a tissue culture lab and cloning operations for 6,925,000 shares of the Company’s common stock.  These assets were acquired from Sam Mac and Eric Tran, respectively, both directors and principal shareholders in the Company.  

 

 

 

Fair Value of Assets Acquired (Liabilities Assumed):

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

Cash

 

 

$8,886  

 

 

Prepaids

 

 

207,704  

 

 

Total assets

 

 

216,590  

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

Accounts payable and accrued liabilities

 

(246,150) 

 

 

Convertible notes payable, net of discount

 

(34,723) 

 

 

Derivative liability

 

 

(743,269) 

 

 

Related party payable

 

 

(19,500) 

 

 

Total liabilities

 

 

(1,043,642) 

 

 

 

 

 

 

 

 

Net liabilities assumed

 

 

$(827,052) 

 

 

 

 

 

 

 

 

Total consideration

 

 

$8,418,901  

 

 

Plus net liabilities assumed

 

 

827,052  

 

 

Goodwill

 

 

$9,245,953  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for the Consortium

 

31,000,000  

 

75.8% 

NewBridge shares prior to acquisition

 

9,904,589  

 

24.2% 

Total shares outstanding following the acquisition

 

40,904,589  

 

100.0% 

 

 

 

 

 

 

Closing price of common stock on July 14, 2018

 

$0.85  

 

 

Total Value of the Company following the acquisition

 

34,768,901  

 

 

Total Consideration (share price x 24.2%)

 

$8,418,901  

 

 

 

 

 

 

 

 

The consideration is 24.2% of the value of the total shares outstanding following the July 14 acquisition.

 

The following presents the pro-forma combined results of operations of the Company with the Consortium as if the acquisition occurred on January 1, 2018.

 

 

 

 

For the nine months ended September 30, 2018

Total revenue

 

 

$36,200  

Net loss allocable to common stockholders

 

$(4,402,727) 

Net loss per common share

 

 

$(0.10) 

Weighted-average number of shares outstanding

 

42,746,557  

 

From the July 14, 2018 acquisition date through September 30, 2018, the acquiree had no revenue and a net loss of $1,515,854.  The pro-forma results of operations are presented for information purposes only.  The pro-forma results of operations are not intended to present actual results that would have been attained had the acquisitions been completed as of January 1, 2018 or to project potential operating results as of any future date or for any future periods.